Instrument Business Outlook Volume 33 - Issue 7
16 Jul 2024
Categories:
Instrument Business Outlook
Table of Contents
-
R&D Spending Shows Little Increases in FY23
- R&D Spending Changes
- R&D vs. Sales Changes
- R&D as a Percentage of Sales
- Foreign Companies
- Conclusion
-
Executive Briefing
- Illumina Makes scRNA-Seq-related Acquisition
- Malvern Panalytical Enters New Markets
- Thermo Fisher Closes Olink Transaction
- Certara Buys Cheminformatics Firm
- Spanish Distributor Acquired
- Indian Firm Lists on Stock Exchanges
-
First Quarter Results: 10x Genomics, Biotage, HORIBA and Pacific Biosciences
- 10x Genomics Posts Mixed Results for First Quarter
- Biotage Sales Helped by Acquisitions
- HORIBA’s Sales Performance in Asia Drives Sales
- Pacific Biosciences Records Sales Headwinds in China
-
Market Profile: Precast Electrophoresis Gels
- Leading Vendors
- Largest Markets
- Instrument Cost
-
Industry Watch
- Biopharma: R&D Spending to Slow in 2024
- Government: Courts Gain New Regulatory Authority
- Clinical: Medical Lab Survey Shows Common KPIs
-
Region Watch
- Europe: Pharma R&D Grows in 2023
- UK: Life Science Indicators Released
- Sri Lanka: Scientific Institutes Survey
-
News
-
Broad-Based Companies
- Company Announcements
-
Life Science Instruments
- Company Announcements
- Product Introductions
- Gene-Based Analysis
- Company Announcements
- Production Introductions
- Cell-Based Analysis
- Company Announcements
- Product Introductions
- Sales & Orders of Note
- Protein-Based Analysis
- Company Announcements
- Product Introductions
- Sales & Orders of Note
-
MS, LC-MS & GC-MS
- Company Announcements
- Product Introductions
- Sales & Orders of Note
-
Laboratory Products
- Laboratory Automation
- Company Announcements
- Product Introduction
- Laboratory Equipment
- Company Announcements
- Product Introductions
- Consumables
- Company Announcements
- Electrochemistry
- Product Introduction
-
Broad-Based Companies
- Bottom Line